Review of Clinical Trial Design: Bayesian and Frequentist Adaptive Methods
Published in Drug information journal : DIJ / Drug Information Association
Interventions Assessment of Prescription Automatic Screening System in Chinese Hospitals: A Systematic Review
Published in Drug information journal : DIJ / Drug Information Association
Objectives To systematically assess the outcomes and effectiveness of Prescription Automatic Screening System (PASS) on rational drug use in China.Methods All studies that evaluated the effects of PASS in Chinese hospitals were electronically searched. Meta-analysis was used to assess the outcomes of intervention effects.Results Twelve articles tha...
Review of Good Clinical Practice: A Question & Answer Reference Guide
Published in Drug information journal : DIJ / Drug Information Association
Review of From Alzheimer’s to Zebrafish: Eclectic Science and Regulatory Stories
Published in Drug information journal : DIJ / Drug Information Association
Associate Editor’s Commentary: In Praise of a BRAT
Published in Drug information journal : DIJ / Drug Information Association
Dispensed Medications: Labeling Patterns and Patient Knowledge at a Tertiary Care University Hospital in Southwest Ethio...
Published in Drug information journal : DIJ / Drug Information Association
The label on dispensed medicines should provide the patient with clear and complete instructions on how to take the drugs. Without sufficient knowledge about risks and benefits of using medicines, people will often not receive the expected clinical outcomes and may suffer adverse effects. The aim of this study was to assess the quality of labeling ...
Are Pharmaceutical Market Withdrawals Preventable? A Preliminary Analysis
Published in Drug information journal : DIJ / Drug Information Association
Some drugs have been removed from the market once it had been determined that their risks outweighed their benefits. Withdrawals negatively impact patients using the drugs as well the pharmaceutical companies who devoted tremendous resources to research, development, and marketing. Therefore, there is a desire to minimize drug withdrawals by learni...
Application of the Benefit-Risk Action Team (BRAT) Framework in Pharmaceutical R&D: Results From a Pilot Program
Published in Drug information journal : DIJ / Drug Information Association
Benefit-risk (B-R) assessments inform decisions regarding drug development and lifecycle management, serve as a basis for regulatory determinations, and help clinicians, patients, and payers make rational, value-based treatment decisions. Nevertheless, no widely accepted, systematic methods exist to guide, justify, and communicate benefit-risk deci...
Editor’s Commentary
Published in Drug information journal : DIJ / Drug Information Association
Clinical Trials: Rethinking How We Ensure Quality
Published in Drug information journal : DIJ / Drug Information Association
